€275,393
▼ Sales (11 ops.)
Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Jones Jeffrey Alan. Insider active across 2 companies, notably Cullinan Oncology, Inc.. In total, 14 disclosures have been published. Split: 0 buy · 11 sells. Total volume traded: €275k. History available since 17 February 2023. The latest transaction was filed on 24 February 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Jones Jeffrey Alan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
4,582 shares@ US$14.4723.2% of flowCommon StockSEC:0001193125-26-072000:0
4,982 shares@ US$13.6223.8% of flowCommon StockSEC:0001193125-26-064257:0
4,632 shares@ US$9.6729.7% of flowCommon StockSEC:0001193125-25-327030:0
4,895 shares@ US$8.5344.2% of flowCommon StockSEC:0000950170-25-029201:0
65,000 shares0Common StockSEC:0000950170-25-025028:0
4,632 shares@ US$11.4155.8% of flowCommon StockSEC:0000950170-24-139124:0
62,500 shares0Common StockSEC:0000950170-24-019455:0
1,860 shares@ US$8.5043.6% of flowCommon StockSEC:0000950170-23-072756:0
386 shares@ US$8.228.8% of flowCommon StockSEC:0000950170-23-071987:0
387 shares@ US$12.9413.9% of flowCommon StockSEC:0000950170-23-029161:0
394 shares@ US$8.769.7% of flowCommon StockSEC:0000899243-23-013361:0
392 shares@ US$10.7111.6% of flowCommon StockSEC:0000950170-23-013705:0
390 shares@ US$11.3212.5% of flowCommon StockSEC:0000899243-23-009717:0
60,000 shares0Common StockSEC:0000899243-23-005728:0
About Jones Jeffrey Alan
Jeffrey Alan Jones is Chief Medical Officer at Cullinan Oncology, Inc. and Cullinan Therapeutics, Inc. He has filed 14 filings in total, and across the 14 sampled filings between 2023-02-21 and 2026-02-25, the recorded transactions are all sales, for a total of EUR 275393.